Becton, Dickinson and Co. | BDX - Cost Of Sales




Becton, Dickinson and Co. reported $2.92B in Cost of Sales for its fiscal quarter ending in September of 2024.

Cost Of Sales Change Date
Abbott USD 4.94B 246M Dec/2024
Agilent USD 785M 62M Oct/2024
Align Technology USD 296.1M 9.76M Sep/2024
Avanos Medical USD 77.5M 4.4M Sep/2024
Baxter International USD 1.67B 715M Sep/2024
Becton, Dickinson and Co. USD 2.92B 239M Sep/2024
Bio-Rad Laboratories USD 293.83M 11.07M Sep/2024
Boston Scientific USD 1.32B 38M Sep/2024
Cooper Companies USD 340.7M 900K Oct/2024
Danaher USD 2.4B 82M Sep/2024
Dentsply International USD 456M 17M Sep/2024
Dexcom USD 400.4M 22.8M Sep/2024
Edwards Lifesciences USD 262.9M 22.4M Sep/2024
Exact Sciences USD 196.07M 6.22M Sep/2024
Globus Medical USD 270.52M 10.48M Sep/2024
Hologic USD 430.2M 36.8M Sep/2024
Insulet USD 166.8M 9.2M Sep/2024
Integra LifeSciences USD 180.6M 11.66M Sep/2024
Intuitive Surgical USD 771.3M 107.1M Dec/2024
J&J USD 6.94B 20M Dec/2024
Masimo USD 241.4M 100K Sep/2024
Medtronic USD 2.94B 183M Oct/2024
Patterson Companies USD 1.35B 0 Oct/2024
Solventum Corp 917M 27M Sep/2024
Stryker USD 1.98B 33M Sep/2024
Tandem Diabetes Care USD 119.32M 10.2M Sep/2024
Teleflex USD 334.2M 973K Sep/2024
Terumo JPY 111.04B 9.59B Sep/2024
Thermo Fisher Scientific USD 6.18B 14M Sep/2024
Zimmer Biomet Holdings USD 538.6M 15M Sep/2024